cabergoline has been researched along with domperidone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
| Husain, M; Manohar, S; Norbury, A; Rogers, RD | 1 |
| Abou-El-Ela Bourquin, B; Bhrugubanda, V; Fu, RZ; Schultz, SR; Seemungal, BM; Yousif, N | 1 |
1 trial(s) available for cabergoline and domperidone
| Article | Year |
|---|---|
Dopamine modulates risk-taking as a function of baseline sensation-seeking trait.
Topics: Adult; Analysis of Variance; Cabergoline; Choice Behavior; Decision Making; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Ergolines; Female; Games, Experimental; Humans; Individuality; Memory, Short-Term; Probability; Risk-Taking; Self Report; Sensation; Young Adult | 2013 |
3 other study(ies) available for cabergoline and domperidone
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Dopamine Activation Preserves Visual Motion Perception Despite Noise Interference of Human V5/MT.
Topics: Adult; Analysis of Variance; Cabergoline; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Ergolines; Female; Humans; Male; Motion; Motion Perception; Noise; Photic Stimulation; Prolactin; Signal-To-Noise Ratio; Transcranial Magnetic Stimulation; Visual Cortex; Young Adult | 2016 |